The NASDAQ-listed company can access discretionary funds through a 36-month agreement with New Jersey’s Yorkville Advisors.
Read more: Wicklow’s Trinity Biotech secures $25m in SEPA funding
Wicklow’s Trinity Biotech secures $25m in SEPA funding
•
•
The NASDAQ-listed company can access discretionary funds through a 36-month agreement with New Jersey’s Yorkville Advisors.
Read more: Wicklow’s Trinity Biotech secures $25m in SEPA funding